ID   ERN2_HUMAN              Reviewed;         926 AA.
AC   Q76MJ5; Q6ZNC0;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   03-MAR-2009, sequence version 2.
DT   02-NOV-2010, entry version 73.
DE   RecName: Full=Serine/threonine-protein kinase/endoribonuclease IRE2;
DE   AltName: Full=Endoplasmic reticulum-to-nucleus signaling 2;
DE   AltName: Full=Inositol-requiring protein 2;
DE            Short=hIRE2p;
DE   AltName: Full=Ire1-beta;
DE            Short=IRE1b;
DE   Includes:
DE     RecName: Full=Serine/threonine-protein kinase;
DE              EC=2.7.11.1;
DE   Includes:
DE     RecName: Full=Endoribonuclease;
DE              EC=3.1.26.-;
DE   Flags: Precursor;
GN   Name=ERN2; Synonyms=IRE2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION,
RP   GLYCOSYLATION, AUTOPHOSPHORYLATION, AND MUTAGENESIS OF LYS-548.
RC   TISSUE=Fetal lung fibroblast;
RX   PubMed=11175748; DOI=10.1038/35055065;
RA   Iwawaki T., Hosoda A., Okuda T., Kamigori Y., Nomura-Furuwatari C.,
RA   Kimata Y., Tsuru A., Kohno K.;
RT   "Tranlational control by the ER transmembrane kinase/ribonuclease IRE1
RT   under ER stress.";
RL   Nat. Cell Biol. 3:158-164(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ARG-271.
RC   TISSUE=Fetal brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-69; CYS-118; CYS-184; ARG-271;
RP   THR-318; PHE-410; SER-487; PHE-504; GLN-537 AND TYR-858.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Induces translational repression through 28S ribosomal
CC       RNA cleavage in response to ER stress. Pro-apoptotic. Appears to
CC       play no role in the unfolded-protein response, unlike closely
CC       related proteins.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: The kinase domain is activated by trans-
CC       autophosphorylation. Kinase activity is required for activation of
CC       the endoribonuclease domain (By similarity).
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass
CC       type I membrane protein.
CC   -!- PTM: Autophosphorylated.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family.
CC   -!- SIMILARITY: Contains 1 KEN domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD18455.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB047079; BAB21297.1; -; mRNA.
DR   EMBL; AK131280; BAD18455.1; ALT_INIT; mRNA.
DR   IPI; IPI00456641; -.
DR   RefSeq; NP_150296.3; -.
DR   UniGene; Hs.592041; -.
DR   ProteinModelPortal; Q76MJ5; -.
DR   STRING; Q76MJ5; -.
DR   Ensembl; ENST00000256797; ENSP00000256797; ENSG00000134398.
DR   GeneID; 10595; -.
DR   KEGG; hsa:10595; -.
DR   CTD; 10595; -.
DR   GeneCards; GC16M023609; -.
DR   H-InvDB; HIX0038529; -.
DR   HGNC; HGNC:16942; ERN2.
DR   HPA; HPA016558; -.
DR   MIM; 604034; gene.
DR   PharmGKB; PA134889542; -.
DR   eggNOG; prNOG14840; -.
DR   HOGENOM; HBG355600; -.
DR   HOVERGEN; HBG051506; -.
DR   InParanoid; Q76MJ5; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 40237; -.
DR   ArrayExpress; Q76MJ5; -.
DR   Bgee; Q76MJ5; -.
DR   CleanEx; HS_ERN2; -.
DR   Genevestigator; Q76MJ5; -.
DR   GermOnline; ENSG00000134398; Homo sapiens.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0016891; F:endoribonuclease activity, producing 5'-pho...; IEA:InterPro.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptosis; IEA:UniProtKB-KW.
DR   GO; GO:0006917; P:induction of apoptosis; IMP:UniProtKB.
DR   GO; GO:0006397; P:mRNA processing; IEA:InterPro.
DR   GO; GO:0016481; P:negative regulation of transcription; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   GO; GO:0016075; P:rRNA catabolic process; IDA:UniProtKB.
DR   GO; GO:0006350; P:transcription; IEA:UniProtKB-KW.
DR   InterPro; IPR010513; KEN_RNase_activator.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR018391; PQQ_beta_propeller_repeat.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR006567; PUG-dom.
DR   InterPro; IPR011047; Quino_AlcDH-like.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   Gene3D; G3DSA:2.140.10.10; Quinoprotein_alc_DH-like; 2.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF06479; Ribonuc_2-5A; 1.
DR   SMART; SM00564; PQQ; 4.
DR   SMART; SM00580; PUG; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF50998; Quin_alc_DH_like; 1.
DR   PROSITE; PS51392; KEN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; ATP-binding; Complete proteome; Endoplasmic reticulum;
KW   Hydrolase; Kinase; Magnesium; Membrane; Metal-binding;
KW   Multifunctional enzyme; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Serine/threonine-protein kinase; Signal; Transcription;
KW   Transcription regulation; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     34       Potential.
FT   CHAIN        35    926       Serine/threonine-protein
FT                                kinase/endoribonuclease IRE2.
FT                                /FTId=PRO_0000024329.
FT   TOPO_DOM     35    430       Lumenal (Potential).
FT   TRANSMEM    431    451       Helical; (Potential).
FT   TOPO_DOM    452    926       Cytoplasmic (Potential).
FT   DOMAIN      520    781       Protein kinase.
FT   DOMAIN      784    912       KEN.
FT   NP_BIND     526    534       ATP (By similarity).
FT   ACT_SITE    637    637       Proton acceptor (By similarity).
FT   BINDING     548    548       ATP.
FT   VARIANT      69     69       V -> I.
FT                                /FTId=VAR_040495.
FT   VARIANT     118    118       R -> C.
FT                                /FTId=VAR_040496.
FT   VARIANT     184    184       R -> C.
FT                                /FTId=VAR_040497.
FT   VARIANT     271    271       Q -> R.
FT                                /FTId=VAR_040498.
FT   VARIANT     318    318       A -> T.
FT                                /FTId=VAR_040499.
FT   VARIANT     410    410       L -> F.
FT                                /FTId=VAR_040500.
FT   VARIANT     487    487       T -> S.
FT                                /FTId=VAR_040501.
FT   VARIANT     504    504       L -> F.
FT                                /FTId=VAR_040502.
FT   VARIANT     537    537       R -> Q (in dbSNP:rs56176960).
FT                                /FTId=VAR_040503.
FT   VARIANT     858    858       H -> Y.
FT                                /FTId=VAR_040504.
FT   MUTAGEN     548    548       K->A: Loss of autophosphorylation, of
FT                                induction of apoptosis and of 28S rRNA
FT                                cleavage, attenuation of repression of
FT                                protein synthesis.
FT   CONFLICT     99     99       Q -> L (in Ref. 1; BAB21297).
FT   CONFLICT    150    150       E -> A (in Ref. 1; BAB21297).
FT   CONFLICT    215    215       G -> E (in Ref. 1; BAB21297).
FT   CONFLICT    218    218       T -> A (in Ref. 1; BAB21297).
FT   CONFLICT    227    227       V -> M (in Ref. 1; BAB21297).
FT   CONFLICT    279    279       T -> A (in Ref. 1; BAB21297).
FT   CONFLICT    320    320       A -> T (in Ref. 1; BAB21297).
FT   CONFLICT    380    380       L -> P (in Ref. 1; BAB21297).
FT   CONFLICT    421    421       T -> I (in Ref. 1; BAB21297).
FT   CONFLICT    453    453       Missing (in Ref. 1; BAB21297).
FT   CONFLICT    468    468       A -> V (in Ref. 1; BAB21297).
FT   CONFLICT    472    474       FAH -> TAD (in Ref. 1; BAB21297).
FT   CONFLICT    486    486       A -> V (in Ref. 1; BAB21297).
FT   CONFLICT    488    491       RRSQ -> LRSK (in Ref. 1; BAB21297).
FT   CONFLICT    528    528       R -> H (in Ref. 1; BAB21297).
FT   CONFLICT    650    650       S -> T (in Ref. 1; BAB21297).
FT   CONFLICT    698    698       D -> N (in Ref. 1; BAB21297).
FT   CONFLICT    738    738       A -> V (in Ref. 1; BAB21297).
FT   CONFLICT    759    759       G -> A (in Ref. 1; BAB21297).
FT   CONFLICT    764    764       P -> L (in Ref. 1; BAB21297).
FT   CONFLICT    768    768       P -> A (in Ref. 1; BAB21297).
FT   CONFLICT    808    808       V -> M (in Ref. 1; BAB21297).
FT   CONFLICT    817    817       A -> T (in Ref. 1; BAB21297).
FT   CONFLICT    833    833       T -> I (in Ref. 1; BAB21297).
FT   CONFLICT    888    888       R -> Q (in Ref. 1; BAB21297).
FT   CONFLICT    896    896       A -> V (in Ref. 1; BAB21297).
FT   CONFLICT    918    918       R -> G (in Ref. 1; BAB21297).
FT   CONFLICT    924    924       T -> A (in Ref. 1; BAB21297).
SQ   SEQUENCE   926 AA;  102466 MW;  6A73B8C958BC50B2 CRC64;
     MASAVRGSRP WPRLGLQLQF AALLLGTLSP QVHTLRPENL LLVSTLDGSL HALSKQTGDL
     KWTLRDDPVI EGPMYVTEMA FLSDPADGSL YILGTQKQQG LMKLPFTIPE LVHASPCRSS
     DGVFYTGRKQ DAWFVVDPES GETQMTLTTE GPSTPRLYIG RTQYTVTMHD PRAPALRWNT
     TYRRYSAPPM DGSPGKYMSH LASCGMGLLL TVDPGSGTVL WTQDLGVPVM GVYTWHQDGL
     RQLPHLTLAR DTLHFLALRW GHIRLPASGP QDTATLFSTL DTQLLMTLYV GKDETGFYVS
     KALVHTGVAL VPRGLTLAPA DGPTTDEVTL QVSGEREGSP STAVRYPSGS VALPSQWLLI
     GHHELPPVLH TTMLRVHPTL GSGTAETRPP ENTQAPAFFL ELLSLSREKL WDSELHPEEK
     TPDSYLGLGP QDLLAASLTA VLLGGWILFV MRQQQPQVVE KQQETPLAPA DFAHISQDAQ
     SLHSGATRRS QKRLQSPSKQ AQPLDDPEAE QLTVVGKISF NPKDVLGRGA GGTFVFRGQF
     EGRAVAVKRL LRECFGLVRR EVQLLQESDR HPNVLRYFCT ERGPQFHYIA LELCRASLQE
     YVENPDLDRG GLEPEVVLQQ LMSGLAHLHS LHIVHRDLKP GNILITGPDS QGLGRVVLSD
     FGLCKKLPAG RCSFSLHSGI PGTEGWMAPE LLQLLPPDSP TSAVDIFSAG CVFYYVLSGG
     SHPFGDSLYR QANILTGAPC LAHLEEEVHD KVVARDLVGA MLSPLPQPRP SAPQVLAHPF
     FWSRAKQLQF FQDVSDWLEK ESEQEPLVRA LEAGGCAVVR DNWHEHISMP LQTDLRKFRS
     YKGTSVRDLL RAVRNKKHHY RELPVEVRQA LGQVPDGFVQ YFTNRFPRLL LHTHRAMRSC
     ASESLFLPYY PPDSEARRPC PGATGR
//
